
Representative · CA-14 · D
Former member (no longer serving)
Current term Jan 3, 2025 – Apr 14, 2026 · In the House since Jan 3, 2013
Official websiteBiographical Directory
Portrait: U.S. Government Publishing Office, via unitedstates/images (public domain)
Lobbying reports (LD-2) whose issue descriptions explicitly cite a bill this member sponsored, cosponsored, or cast a recorded vote on. This documents an overlap in subject only. LD-2 reports generally do not name the members contacted, and a citation does not show contact with this member, influence, or the client's position on the bill. No matching record means none was found within coverage, not that no lobbying occurred.
Loading lobbying reportsCoverage: LD-2 reports for 2025 onward, posted Jan 1, 2025 through Oct 28, 2026. Only the current version of each report is used.
43,426 report citations, newest first.
SOLAREDGE TECHNOLOGIES INC. · lobbying firm or registrant: SOLAREDGE TECHNOLOGIES INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Oct 20, 2026 · issue area: Energy/Nuclear
$180,000
Spent on own lobbying
CitesH.Con.Res. 14· this member:Recorded votes on 2 roll calls
…garding sections 45X, 48 and 48E. Education regarding Cyber security related to photovoltaic systems as critical infrastructure. Solar permitting improvements. H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal yea…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOLAREDGE TECHNOLOGIES INC. · lobbying firm or registrant: SOLAREDGE TECHNOLOGIES INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Oct 20, 2026 · issue area: Energy/Nuclear
$180,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 3 roll calls
…gressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034 - H.R. 1, One Big Beautiful Bill Act - clean energy tax credits and implementation of H.R. 1.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOLAREDGE TECHNOLOGIES INC. · lobbying firm or registrant: SOLAREDGE TECHNOLOGIES INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Oct 20, 2026 · issue area: Environment/Superfund
$180,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 3 roll calls
…gressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034 - H.R. 1, One Big Beautiful Bill Act - clean energy tax credits and the implementation of H.R. 1.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOLAREDGE TECHNOLOGIES INC. · lobbying firm or registrant: SOLAREDGE TECHNOLOGIES INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Oct 20, 2026 · issue area: Taxation/Internal Revenue Code
$180,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 3 roll calls
…gressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034 - H.R. 1, One Big Beautiful Bill Act - clean energy tax credits and the implementation of H.R. 1.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
TOYOTA MOTOR NORTH AMERICA, INC. · lobbying firm or registrant: INVARIANT LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Consumer Issues/Safety/Products
$90,000
Paid to lobbying firm
CitesH.R. 5221· this member:Cosponsored
Monitor H.R.1566, the REPAIR Act; H.R. 6687, the DRIVER Act; H.R. 5221, PART Act; the introduction of the SAFE Repair Act draft; and right-to-repair issues.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GSK (FKA GLAXOSMITHKLINE INC.) · lobbying firm or registrant: GSK (FKA GLAXOSMITHKLINE INC.)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$1,530,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 3 roll calls
H.R. 6500: Continuing Appropriations and Extensions Act, 2027 (Public Law 119-103) Presidents Budget Fiscal Year 2027 H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriation…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GSK (FKA GLAXOSMITHKLINE INC.) · lobbying firm or registrant: GSK (FKA GLAXOSMITHKLINE INC.)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$1,530,000
Spent on own lobbying
CitesH.R. 6500· this member:Recorded vote on 1 roll call
H.R. 6500: Continuing Appropriations and Extensions Act, 2027 (Public Law 119-103) Presidents Budget Fiscal Year 2027 H.R. 1: One Big Beautiful Bill Act (Public Law No.…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GSK (FKA GLAXOSMITHKLINE INC.) · lobbying firm or registrant: GSK (FKA GLAXOSMITHKLINE INC.)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$1,530,000
Spent on own lobbying
CitesH.R. 6938· this member:Recorded votes on 3 roll calls
…man Services, and Education, and Related Agencies Appropriations Act, 2027 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (P.L. 119-74) S. 2354: Commerce, Justice, Scie…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GSK (FKA GLAXOSMITHKLINE INC.) · lobbying firm or registrant: GSK (FKA GLAXOSMITHKLINE INC.)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$1,530,000
Spent on own lobbying
CitesH.R. 7148· this member:Recorded votes on 4 roll calls
…on Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Government funding polic…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GSK (FKA GLAXOSMITHKLINE INC.) · lobbying firm or registrant: GSK (FKA GLAXOSMITHKLINE INC.)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$1,530,000
Spent on own lobbying
CitesS. 1071· this member:Recorded votes on 2 roll calls
…lopment; and Interior and Environment Appropriations Act, 2026 (P.L. 119-74) S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No: 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: Na…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GSK (FKA GLAXOSMITHKLINE INC.) · lobbying firm or registrant: GSK (FKA GLAXOSMITHKLINE INC.)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$1,530,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 3 roll calls
…S. 3788: CLEAR LABELS Act S. 3794: SAFE Drugs Act of 2026 S. 4189: INSULIN Act of 2026 S. 5043: Secure Drug Supply Chain Act of 2026 S. 5244: SUSTAIN 340B Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiat…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GSK (FKA GLAXOSMITHKLINE INC.) · lobbying firm or registrant: GSK (FKA GLAXOSMITHKLINE INC.)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$1,530,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 3 roll calls
H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4299: Protecting Patient Access to Cancer and Complex Therapies Act H.R. 10628: Biosimilars Access and…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
JPMORGAN CHASE HOLDINGS LLC · lobbying firm or registrant: JPMORGAN CHASE HOLDINGS LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Banking
$1,460,000
Spent on own lobbying
CitesH.R. 6644· this member:Recorded vote on 1 roll call
S. 401, H.R. 3234, H.R. 6644, S. 4198, H.R. 6955, H.R. 10167 - Discussed bank regulatory policy. Discussed mortgage loan originations, servicing and refinancing, and related issues.
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
JPMORGAN CHASE HOLDINGS LLC · lobbying firm or registrant: JPMORGAN CHASE HOLDINGS LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Financial Institutions/Investments/Securities
$1,460,000
Spent on own lobbying
CitesH.R. 3633· this member:Recorded vote on 1 roll call
H.R. 3633, S. 3017, H.R. 1799, H.R. 2152, H.R. 4801, H.R. 8278, H.R. 9925 - Discussed margin issues and CCPs. Discussed issues related to bank structure, capital require…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOLANA POLICY INSTITUTE · lobbying firm or registrant: FEDERAL HALL POLICY ADVISORS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Financial Institutions/Investments/Securities
$20,000
Paid to lobbying firm
CitesH.R. 3633· this member:Recorded vote on 1 roll call
…entralized finance, digital rights, regulatory framework for stablecoins, and central bank digital currency regulations and proposals (S. 4428 SAFE Crypto Act; H.R. 3633 CLARITY Act; H.R. 7732 Promoting Innovation in Blockchain Development Act; H.R. 3533/ S. 3611 Blockchain Regulatory Certainty Act; S. 4064 Digital Asset Market…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ALLIANCE FOR AUTOMOTIVE INNOVATION · lobbying firm or registrant: ALLIANCE FOR AUTOMOTIVE INNOVATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Automotive Industry
$1,502,541
Spent on own lobbying
CitesH.J.Res. 88· this member:Recorded vote on 1 roll call
HR 2110: Safe Vehicle Access for Survivors Act HR 9615: Battery Recycling for America's Competitive Economy Act (BRACE) Act H.J.Res.88: California State Motor Vehicle and Engine Pollution Control Standards; Advanced Clean Cars II; Waiver of Preemption S. 315: AM Radio for Every Vehicle Act of…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
VISA · lobbying firm or registrant: AVOQ, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Financial Institutions/Investments/Securities
$60,000
Paid to lobbying firm
CitesH.R. 3633· this member:Recorded vote on 1 roll call
…ated to credit card interchange; Issues relating to H.R. 7035/S. 3623, the Credit Card Competition Act; General monitoring of issues related to digital assets; H.R. 3633, Digital Asset Market Clarity Act of 2025; Issues related to artificial intelligence (AI)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BRANDT HOLDINGS CO · lobbying firm or registrant: SHUMAKER ADVISORS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Agriculture
$15,000
Paid to lobbying firm
CitesH.R. 1· this member:Recorded votes on 3 roll calls
HR 1 (OBBB)
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GRAIL, INC. · lobbying firm or registrant: BALLARD SPAHR LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$20,000
Paid to lobbying firm
CitesH.R. 842· this member:Cosponsored
H.R. 842/ S. 339 Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GRAIL, INC. · lobbying firm or registrant: BALLARD SPAHR LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$20,000
Paid to lobbying firm
CitesH.R. 842· this member:Cosponsored
H.R. 842/ S. 339 Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; veteran access to the Galleri test
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AIRBNB, INC. · lobbying firm or registrant: AIRBNB, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Housing
$270,000
Spent on own lobbying
CitesH.R. 6644· this member:Recorded vote on 1 roll call
H.R. 6644: 21st Century ROAD to Housing Act; all provisions
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CENTER FOR COMMUNITY CHANGE ACTION · lobbying firm or registrant: CENTER FOR COMMUNITY CHANGE ACTION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Family issues/Abortion/Adoption
$10,000
Spent on own lobbying
CitesH.R. 4418· this member:Cosponsored
H.R.5658\S.2939 - Child Care for Every Community Act; H.R.4418/S.2295 - Child Care for Working Families Act; Privite equity and Childcare.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
LOCKHEED MARTIN CORPORATION · lobbying firm or registrant: LOCKHEED MARTIN CORPORATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Aerospace
$4,090,000
Spent on own lobbying
CitesH.R. 6500· this member:Recorded vote on 1 roll call
HR 6500 - Continuing Appropriations and Extensions Act, 2027 including issues related to civil space; S (not yet introduced)/HR 8845 - Commerce, Justice, Science, and…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN DENTAL ASSOCIATION · lobbying firm or registrant: AMERICAN DENTAL ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$210,000
Spent on own lobbying
CitesH.R. 6500· this member:Recorded vote on 1 roll call
H.R. 9260, H.R. 9171, H.R. 8800, H.R. 8469, H.R. 6500 - FY27 appropriations for dentistry and oral health funding, including federal oral health prevention programs, military dental research, NIH/NIDCR funding, VA…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN DENTAL ASSOCIATION · lobbying firm or registrant: AMERICAN DENTAL ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Education
$210,000
Spent on own lobbying
CitesH.R. 3711· this member:Cosponsored
…th Center, GME, National Health Service Corps and Community Health Center reauthorization H.R. 2028/ S. 942 Resident Education Deferred Interest Act (REDI Act) H.R. 3711/S. 1948 Protecting Our Students by Terminating Graduate Rates that Add to Debt Act (POST GRAD Act) H.R. 3885, Community Training, Education, and Access for Med…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing